Optimizing the strategic value of your lab: Q&A with Noel Maring

Noel Maring, executive director of health systems at Labcorp, answers questions healthcare executives may have around optimizing the strategic value of their lab. 

Lab stewardship program reduces unnecessary costs and improves patient care

A large, Chicago-based FQHC network wanted to optimize efficiency of testing, improve patient care and provide better, more accurate testing for their highrisk population, while also eliminating unnecessary testing expenses. The network, however, faced a lack of population health analytics tools and limited funding to invest in developing their own.

Using clinical lab data to improve diabetes outcomes in underserved populations

More than 37 million Americans (more than 11% of the population) have diabetes.1 This statistic alone highlights the need to improve patient care, especially in underserved populations where incidence of the disease is high.

Analytics lets labs offset staffing woes

For hospital laboratories confronting worker shortages, data analytics can be useful for improving workflows and determining effective staffing levels. This information can also induce changes that may improve employee morale. Two experts from Visiun, a Labcorp subsidiary, discuss three analytics reports that should be available for clinical lab managers juggling staffing concerns.

How one company used lab data insights to improve population management of chronic kidney disease (CKD)

When one of New Jersey’s largest independent physician associations (IPA) entered into a value-based care contract, they intensified their focus on identifying and managing their chronic kidney disease (CKD) population with a few goals in mind:

Finding silver linings during the pandemic: An interview with Dr. Christopher Dale of Swedish Health System.

  Labcorp’s Dr. Brian Caveney conducted a fireside interview chat with Dr. Christopher Dale of Swedish Health System.

Dr. Caveney interviews three hospital leaders during the early days of the pandemic

In mid-2021, as COVID-19 cases continued to surge, three of Labcorp’s hospital leader partners each sat down for a recorded interview with Dr. Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics. They shared their experiences from the onset of the pandemic and specific steps they took to overcome new challenges.

Refining your ambulatory laboratory strategy: A guide

Adapting ambulatory lab services in an evolving healthcare landscape is challenging. In our experience, most health systems face three challenges when developing or evaluating their ambulatory lab strategy: Understanding the strategic value, calculating the long-term investment and finding the right partner for success.